Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease

Kathleen E. Corey, Naga Chalasani

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the United States and is associated with an increased risk of cardiovascular disease (CVD) and cardiovascular (CV) mortality, independent of traditional cardiovascular risk factors. CVD is one of the most common causes of death among individuals with NAFLD and management of NAFLD must extend beyond liver disease to include CVD risk modification. Clinicians should assess CVD risk with the Framingham Risk Score and screen for CVD risk factors including dyslipidemia, diabetes mellitus, hypertension, tobacco use, and the metabolic syndrome. CVD risk factors, particularly dyslipidemia, require aggressive medical management to reduce the high risk of CVD events and death in individuals with NAFLD.

Original languageEnglish
Pages (from-to)1077-1084
Number of pages8
JournalClinical Gastroenterology and Hepatology
Volume12
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Dyslipidemias
Cardiovascular Diseases
Liver Diseases
Tobacco Use
Disease Management
Non-alcoholic Fatty Liver Disease
Cause of Death
Diabetes Mellitus
Hypertension
Mortality

Keywords

  • Cardiovascular disease
  • Dyslipidemia
  • Nonalcoholic fatty liver disease

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. / Corey, Kathleen E.; Chalasani, Naga.

In: Clinical Gastroenterology and Hepatology, Vol. 12, No. 7, 2014, p. 1077-1084.

Research output: Contribution to journalArticle

@article{850d2e59e3704328855bb12b0675e404,
title = "Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease",
abstract = "Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the United States and is associated with an increased risk of cardiovascular disease (CVD) and cardiovascular (CV) mortality, independent of traditional cardiovascular risk factors. CVD is one of the most common causes of death among individuals with NAFLD and management of NAFLD must extend beyond liver disease to include CVD risk modification. Clinicians should assess CVD risk with the Framingham Risk Score and screen for CVD risk factors including dyslipidemia, diabetes mellitus, hypertension, tobacco use, and the metabolic syndrome. CVD risk factors, particularly dyslipidemia, require aggressive medical management to reduce the high risk of CVD events and death in individuals with NAFLD.",
keywords = "Cardiovascular disease, Dyslipidemia, Nonalcoholic fatty liver disease",
author = "Corey, {Kathleen E.} and Naga Chalasani",
year = "2014",
doi = "10.1016/j.cgh.2013.08.014",
language = "English",
volume = "12",
pages = "1077--1084",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease

AU - Corey, Kathleen E.

AU - Chalasani, Naga

PY - 2014

Y1 - 2014

N2 - Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the United States and is associated with an increased risk of cardiovascular disease (CVD) and cardiovascular (CV) mortality, independent of traditional cardiovascular risk factors. CVD is one of the most common causes of death among individuals with NAFLD and management of NAFLD must extend beyond liver disease to include CVD risk modification. Clinicians should assess CVD risk with the Framingham Risk Score and screen for CVD risk factors including dyslipidemia, diabetes mellitus, hypertension, tobacco use, and the metabolic syndrome. CVD risk factors, particularly dyslipidemia, require aggressive medical management to reduce the high risk of CVD events and death in individuals with NAFLD.

AB - Nonalcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the United States and is associated with an increased risk of cardiovascular disease (CVD) and cardiovascular (CV) mortality, independent of traditional cardiovascular risk factors. CVD is one of the most common causes of death among individuals with NAFLD and management of NAFLD must extend beyond liver disease to include CVD risk modification. Clinicians should assess CVD risk with the Framingham Risk Score and screen for CVD risk factors including dyslipidemia, diabetes mellitus, hypertension, tobacco use, and the metabolic syndrome. CVD risk factors, particularly dyslipidemia, require aggressive medical management to reduce the high risk of CVD events and death in individuals with NAFLD.

KW - Cardiovascular disease

KW - Dyslipidemia

KW - Nonalcoholic fatty liver disease

UR - http://www.scopus.com/inward/record.url?scp=84902547007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902547007&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2013.08.014

DO - 10.1016/j.cgh.2013.08.014

M3 - Article

VL - 12

SP - 1077

EP - 1084

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 7

ER -